Sandrine Moutel

This inventor holds 6 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Institut Curie, National Institute of Health and Medical Research. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sandrine Moutel. Retrieved from https://idiyas.com/inventor/sandrine-moutel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 6 (Patent Applications = 5)

% Patents Active = 83.3

EPO Patents = 1 (Patent Applications = 7)

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

5 out of 5,383

Centre National De La Recherche Scientifique

National Institute of Health and Medical Research

patents

4. 4 out of 162

Université Paul Sabatier (Toulouse III)

where one patent can have more than one assignee

Years Active: 2018-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12594302 - Single Domain Antibodies and Their Use in Cancer Therapies (2026-04-07),

2. 11866484 - Synthetic single domain antibody (2024-01-09),

3. 11014977 - Synthetic single domain antibody (2021-05-25),

4. 10968281 - Anti-LSP1 antibody (2021-04-06),

5. 10030068 - Synthetic single domain antibody (2018-07-24),

6. 10017559 - Synthetic single domain antibody (2018-07-10),

Title: Sandrine Moutel: Innovator in Synthetic Antibody Technology

Introduction

Sandrine Moutel is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of synthetic single domain antibodies. With a total of five patents to her name, her work has the potential to revolutionize therapeutic applications.

Latest Patents

Among her latest patents is the invention related to a highly stable single domain antibody scaffold known as hs2dAb. This invention focuses on generating a synthetic single domain antibody library, referred to as hs2dAb-L1. The patent also encompasses antigen-binding proteins that utilize this stable scaffold, highlighting their potential use as therapeutics.

Career Highlights

Sandrine has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Institut Curie. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.

Collaborations

Throughout her career, Sandrine has collaborated with notable colleagues, including Franck Perez and Aurelien Olichon. These partnerships have further enriched her research and innovation in the field.

Conclusion

Sandrine Moutel stands out as a leading inventor in the realm of synthetic antibodies. Her innovative work and collaborations continue to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.